GSK Launches Relvar For Asthma In Japan, First ICS/LABA Administered Once A Day
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline has launched Relvar and Ellipta (fluticasone furoate/vilanterol) for bronchial asthma in Japan.